CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01547767
NCT01547767N/ACompleted

Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy

In Brief

An observational study for Myopathy. Completed, enrolled 2 participants across 1 site.

Detailed Summary

Background: \- A mutation in a gene known as ISCU was found to be the cause of a rare myopathy that affects the muscles. Researchers collected clinical samples from people with this myopathy. More research is being done to develop a therapy for this disease. Researchers are asking for permission to study the samples already collected. Objectives: \- To allow researchers to use clinical samples collected to study new treatments for ISCU myopathy. Eligibility: \- People with ISCU myopathy who have provided clinical samples for study. Design: * Participants will allow researchers to study clinical samples already collected. Blood, urine, muscle, and cell samples may be used. Medical records and photographs may also be studied. * Treatment will not be provided as part of this study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyopathy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 8, 2012
Enrollment StartFeb 1, 2012
Primary CompletionMar 3, 2021
TodayJul 2, 2026
Enrollment to primary: 9.1 yearsPosted 14.3 years ago